# Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

> **NCT06516042** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **PATH** · enrollment: 10350 (estimated)

## Conditions studied

- Plasmodium Falciparum
- Malaria

## Interventions

- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT06516042
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-21
- **Primary completion:** 2025-01-24
- **Final completion:** 2025-07
- **Target enrollment:** 10350 (ESTIMATED)
- **Last updated:** 2025-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06516042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06516042, "Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06516042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*